Quantcast
Last updated on April 17, 2014 at 13:15 EDT

Latest Cytomegalovirus Stories

2013-12-17 08:28:59

MILFORD, Mass., Dec. 17, 2013 /PRNewswire/ -- SeraCare Life Sciences, a provider of high quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced a new CMV DNA AccuSpan(TM) Linearity Panel. This new offering is a nine member panel made from serial dilutions of a cultured virus with established reactivity for CMV DNA. (Photo: http://photos.prnewswire.com/prnh/20131217/NE33384) Cytomegalovirus...

2013-10-24 23:20:07

Reportbuyer.com just published a new market research report: Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013. London (PRWEB) October 24, 2013 Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013" provides data on the Cytomegalovirus (HHV-5) Infections clinical trial scenario. This report provides elemental...

2013-09-18 13:28:52

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus. The first-of-its-kind approach to preventing human CMV infection, developed by a team of scientists at UC Davis and the University of Alabama, Birmingham, induced broader...

2013-09-17 23:01:05

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus. Sacramento, PA (PRWEB) September 17, 2013 An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients,...

2013-08-01 23:26:03

According to a study published in the journal, Immunity and Aging on July 23, 2013, the concept of accelerating decline in the immune system caused by persistent infections has been suggested in many studies.(1) polyDNA recommends Gene-Eden-VIR to boost the immune system against latent viruses. Rochester, NY (PRWEB) August 01, 2013 Aging and latent viruses join forces in a vicious cycle. Aging decreases the efficiency of the immune system. As a result, the concentration of latent viruses...

2013-07-25 23:21:44

“Approximately one in five children with congenital CMV infection will develop permanent problems, such as hearing loss or developmental disabilities" according to an article published on July 12, 2013 in The Standard Examiner (1). polyDNA recommends cleansing the future parents’ bodies from viruses which may harm the baby. Rochester, NY (PRWEB) July 25, 2013 Women worried about having a healthy baby should ask their home states to copy the health initiative recently adopted by...

2013-06-14 23:21:03

During the month of June, which is Congenital Cytomegalovirus Awareness Month, polyDNA highlights the dangers newborns face when CMV is passed from the mother to the child during childbirth. Rochester, NY (PRWEB) June 14, 2013 During the month of June, polyDNA will be lowering the price of Gene-Eden-VIR by 50% for women planning to become pregnant and who have a latent cytomegalovirus (CMV) infection verified by a doctor. polyDNA is a leading producer of natural CMV remedies. As the CDC...

2013-03-13 17:52:05

La Jolla Institute and Cardiff University discovery aids efforts toward cytomegalovirus vaccine A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today. Because of cytomegalovirus (CMV) infection during in utero development, 1 in 750 children are born with or develop permanent disabilities such as hearing loss or brain damage. But efforts to develop a first-ever CMV vaccine are gaining...

2012-11-23 10:53:50

Ribosome-mapping technique may provide insights into other viral proteomes as well New findings reveal the surprisingly complex protein-coding capacity of the human cytomegalovirus, or HCMV, and provide the first steps toward understanding how the virus manipulates human cells during infection. The genome of the HCMV was first sequenced over 20 years ago, but researchers have now investigated the proteome–the complete set of expressed proteins–of this common pathogen as well....

2012-09-21 06:27:01

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2012 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced data highlighting the significant morbidity and resource utilization associated with the current standard of care for the management of cytomegalovirus (CMV) infection in hematopoietic stem cell transplant (HSCT) recipients. This analysis, entitled "Preemptive Therapy (PrT) for Cytomegalovirus (CMV) Post-hematopoietic Cell...


Latest Cytomegalovirus Reference Libraries

0_bbd337098cfaf28eafeb5f5f010e48ef
2011-01-12 15:30:34

Cytomegalovirus, a herpes viral genus, is known in humans as HCMV. It is part of the Betaherpesvirinae subfamily. Other herpesviruses fall into the subfamilies of Alphaherpesvirinae or Gammaherpesvirinae. xHCMV infections are frequently associated with salivary glands. It can be lethal for people who are immunocompromised. Other CMV viruses are found in several mammal species, but species isolated from animals differ from HCMV in terms of genomic structure. HCMV is found all over the...

More Articles (1 articles) »